Bilcare P/B Ratio
Bilcare (BI) P/B ratio is 0.33 (Low), book value per share ₹245.83 vs Healthcare average P/B of -0.32 — Very Low - Significant discount to book value, potential distress or value opportunity. Compare with BI fair value estimate to assess whether the stock is under or overvalued.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
BI P/B Ratio — Valuation Insights & Book Value Analysis
Bilcare price-to-book ratio interpretation, valuation status and historical context — current P/B 0.33 (Low). For live price, earnings yield and the full fundamental profile, see Bilcare share price screener.
- Stock appears undervalued with PB of 0.33, trading below book value
- Trading below book value - potential value opportunity or financial distress signal
- Current PB is 37.0% below historical average
- Trading at premium to sector average PB of -0.32
Bilcare P/B Ratio Historical Trend
BI annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View BI 52-week performance for the annual high/low range and current price position.
BI Historical P/B Ratio — Book Value Per Share & Year-End Price
Bilcare annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 0.32 | ₹245.83 | ₹79.67 | ₹590 | Low |
| 2024 | 0.24 | ₹269.17 | ₹65.57 | ₹646 | Low |
| 2023 | 0.27 | ₹293.33 | ₹79.03 | ₹704 | Low |
| 2022 | 0.57 | ₹67.08 | ₹38.00 | ₹161 | Low |
| 2021 | 1.22 | ₹68.33 | ₹83.30 | ₹164 | Moderate |
BI vs Healthcare Peers — P/B Ratio Comparison
Bilcare P/B 0.33 vs Healthcare average -0.32, median 0.63 — range -17.92–1.01.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -17.92 | ₹22 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Parmax Pharma | PARMAX | -2.48 | ₹14 | Low |
| Bharat Immunologicals | BIBCL | -2.32 | ₹76 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹127 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.63 | ₹53 | Low |